Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Clin Infect Dis ; 76(10): 1753-1760, 2023 05 24.
Artículo en Inglés | MEDLINE | ID: mdl-36750643

RESUMEN

BACKGROUND: Small sample sizes have limited prior studies' ability to capture severe COVID-19 outcomes, especially among Ad26.COV2.S vaccine recipients. This study of 18.9 million adults aged ≥18 years assessed relative vaccine effectiveness (rVE) in three recipient cohorts: (1) primary Ad26.COV2.S vaccine and Ad26.COV2.S booster (2 Ad26.COV2.S), (2) primary Ad26.COV2.S vaccine and mRNA booster (Ad26.COV2.S+mRNA), (3) two doses of primary mRNA vaccine and mRNA booster (3 mRNA). METHODS: We analyzed two de-identified datasets linked using privacy-preserving record linkage (PPRL): insurance claims and retail pharmacy COVID-19 vaccination data. We assessed the presence of COVID-19 diagnosis during January 1-March 31, 2022 in: (1) any claim, (2) outpatient claim, (3) emergency department (ED) claim, (4) inpatient claim, and (5) inpatient claim with intensive care unit (ICU) admission. rVE for each outcome comparing three recipient cohorts (reference: two Ad26.COV2.S doses) was estimated from adjusted Cox proportional hazards models. RESULTS: Compared with two Ad26.COV2.S doses, Ad26.COV2.S+mRNA and three mRNA doses were more effective against all COVID-19 outcomes, including 57% (95% CI: 52-62) and 62% (95% CI: 58-65) rVE against an ED visit; 44% (95% CI: 34-52) and 54% (95% CI: 48-59) rVE against hospitalization; and 48% (95% CI: 22-66) and 66% (95% CI: 53-75) rVE against ICU admission, respectively. CONCLUSIONS: This study demonstrated that Ad26.COV2.S + mRNA doses were as good as three doses of mRNA, and better than two doses of Ad26.COV2.S. Vaccination continues to be an important preventive measure for reducing the public health impact of COVID-19.


Asunto(s)
COVID-19 , SARS-CoV-2 , Adulto , Humanos , Adolescente , COVID-19/epidemiología , COVID-19/prevención & control , Ad26COVS1 , Prueba de COVID-19 , Vacunas contra la COVID-19 , Vacunación , ARN Mensajero
2.
BMC Nutr ; 8(1): 108, 2022 Oct 03.
Artículo en Inglés | MEDLINE | ID: mdl-36192812

RESUMEN

BACKGROUND: To evaluate the impact of home-delivered, medically tailored meals and medical nutrition therapy among food-insecure patients following hospitalization for congestive heart failure by comparing clinical outcomes to a retrospectively matched cohort. METHODS: Patients at high risk for readmission and food insecurity received up to three months of medically tailored meals and medical nutrition therapy after discharge. Pre-intervention and post-intervention weight, body mass index, blood pressure, and dietary intake were assessed. A combination of difference-in-difference and logistic regression models were used to compare changes between cohorts and evaluate impact attributable to the program. RESULTS: Thirty-nine program participants were compared to a matched cohort of 117 unexposed patients. Participants experienced a marginal reduction in body mass index and an increase in systolic and diastolic blood pressure; however, these results were not statistically significant. To determine relevance to clinical cut-offs, logistic regressions were used, demonstrating that exposure to the intervention resulted in higher odds of a categorical reduction in blood pressure (OR: 1.85), though this did not reach statistical significance (95% CI: 0.67-5.32). Pre vs. post trends indicated that more-healthful foods and drinks increased numerically or remained similar to baseline, while less-healthful foods decreased numerically or remained similar to baseline. CONCLUSIONS AND IMPLICATIONS: These findings highlight the need for more longitudinal research on medically tailored meals and medical nutrition therapy interventions using clinical outcomes while setting realistic suggestions for program implementation. This study additionally illustrates the promise of integrating electronic medical record data and matched cohorts into medical nutrition program evaluation within the health sector.

3.
Am J Med Qual ; 35(4): 315-322, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31701768

RESUMEN

Screening for depression is paramount to identify patients with depression and link them to care, yet only 29% of patients in the primary care center (PCC) were screened for depression in 2016. A baseline survey identified provider barriers to depression screening, including lack of time, support staff, and referral resources. The purpose of this project was to increase depression screening in the PCC using the Patient Health Questionnaire (PHQ-2/9). The authors created an educational program for staff and providers that included referral resources, treatment guidelines, and a decision-support tool in the electronic medical record. A retrospective chart review was performed, from January 2016 to June 2017, to determine the percentage of patients who received annual depression screening. During the program, the PCC saw an increase in depression screening rates. Thus, it is possible to overcome barriers to depression screening in a primary care setting by providing resources and education to clinicians.


Asunto(s)
Depresión/diagnóstico , Tamizaje Masivo/organización & administración , Atención Primaria de Salud/organización & administración , Población Urbana , Poblaciones Vulnerables , Centros Médicos Académicos , Negro o Afroamericano , Actitud del Personal de Salud , Enfermedad Crónica , Comorbilidad , Alfabetización en Salud , Humanos , Derivación y Consulta , Estudios Retrospectivos
4.
Environ Res ; 109(3): 292-300, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19144330

RESUMEN

OBJECTIVES: We explored potential effects of cadmium exposure on cardiovascular fitness measures, including gender and racial/ethnic differences. METHODS: Data were from the 1999 to 2000 National Health and Nutrition Examination Survey (NHANES); 1963 participating subjects were included in our analysis. Volume of oxygen consumed at sub-maximum activity (VO(2) max) were recorded in a series of graded exercises; the goal was to elicit 75% of predetermined age-specific heart rates. Cadmium from urine samples was measured in the laboratory using standard methods. Multivariate linear regression analyses were performed to determine potential relationships. RESULTS: Increased urinary cadmium concentrations were generally associated with decreased estimated VO(2) max values. Gender and racial/ethnic differences were also observed. Specifically, associations were statistically significant for white males and Mexican American females. CONCLUSION: Inverse associations between urinary cadmium concentrations and estimated VO(2) max values were observed, including racial and gender differences. The implications of such gender and racial/ethnic differences on long-term cardiovascular health and health disparities of present public health concern warrant further investigation.


Asunto(s)
Cadmio/orina , Fenómenos Fisiológicos Cardiovasculares/efectos de los fármacos , Contaminantes Ambientales/orina , Consumo de Oxígeno , Adolescente , Adulto , Población Negra , Niño , Estudios Transversales , Prueba de Esfuerzo , Femenino , Humanos , Modelos Lineales , Masculino , Americanos Mexicanos , Persona de Mediana Edad , Factores Sexuales , Factores Socioeconómicos , Población Blanca , Adulto Joven
5.
J Bone Miner Res ; 30(12): 2215-20, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26011289

RESUMEN

Poor renal function is associated with increased rates of bone loss and osteoporotic fractures in Caucasian men. The importance of kidney function for skeletal health in African ancestry men, who are a population segment with a high prevalence of chronic kidney disease as well as high peak bone mass, is not well known. We examined the relationship between estimated glomerular filtration rate (eGFR) and rates of bone loss in a large population cohort of otherwise healthy Afro-Caribbean men aged 40 years and older. Dual X-ray absorptiometry of the proximal femur and quantitative computed tomography of the proximal radius and tibia were obtained approximately 6 years apart. We calculated eGFR from serum creatinine that was measured in fasting samples in 1451 men. Impaired kidney function (IKF, eGFR<60 ml/min/1.7 m(2)) was observed in 8.6% of the cohort. The relationship between IKF and baseline BMD and annualized rate of change in BMD was analyzed controlling for potentially important confounders. IKF was not associated with baseline BMD. In contrast, men with IKF experienced a rate of decline in areal BMD at the total hip, femoral neck and trochanter and cortical volumetric BMD compared to those with normal kidney function (p<0.05 for all). Impaired kidney function was not associated with changes in trabecular volumetric BMD. In conclusion, poorer kidney function is associated with accelerated bone loss among otherwise healthy Afro-Caribbean men even after controlling for age and other important medical and lifestyle related variables.


Asunto(s)
Densidad Ósea , Enfermedades Óseas Metabólicas/diagnóstico por imagen , Enfermedades Óseas Metabólicas/etnología , Fallo Renal Crónico/diagnóstico por imagen , Fallo Renal Crónico/etnología , Riñón/fisiopatología , Absorciometría de Fotón , Adulto , Anciano , Anciano de 80 o más Años , Antropometría , Población Negra , Peso Corporal , Huesos/patología , Región del Caribe , Estudios de Cohortes , Densitometría , Fémur/diagnóstico por imagen , Cuello Femoral/diagnóstico por imagen , Tasa de Filtración Glomerular , Cadera/diagnóstico por imagen , Humanos , Riñón/fisiología , Pruebas de Función Renal , Estilo de Vida , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda